| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.21 | 0.0001 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0006 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |